, Volume 43, Issue 2, pp 412–418 | Cite as

Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects

Original Article


Both altered GH-IGF-I axis and low serum levels of 25-hydroxyvitamin D (25(OH)D) are linked to measures of metabolic syndrome. Our hypothesis was that there is a relation between GH, IGF-I, and 25(OH)D; and that vitamin D supplementation may have an effect on the levels of GH, IGF-I, and IGF-I/IGFBP-3 ratio. 318 overweight and obese subjects completed a one-year randomized intervention with either 40,000 or 20,000 IU cholecalciferol per week or placebo. GH, IGF-I, IGFBP-3 and measures of insulin resistance were evaluated at baseline and at the end of study. There was a significant relation between entities of GH-IGF-I axis and insulin resistance. Subjects with severe obesity had significantly lower serum 25(OH)D and had a significant linear decline in IGF-I/IGFBP-3 ratio with increasing serum 25(OH)D quartiles. Vitamin D status was an independent predictor of GH-IGF-I axis and supplementation with vitamin D decreased IGF-I/IGFBP-3 ratio in subjects without severe obesity. No corresponding effect of vitamin D supplementation on BMI or insulin resistance was observed. Adverse effects of GH-IGF-I axis on glucose metabolism and the development of metabolic syndrome may be in part associated with the changes in vitamin D status.


Growth hormone IGF-I Vitamin D Obesity Insulin resistance 


  1. 1.
    J.M. Gómez, F.J. Maravall, N. Gómez, M.A. Navarro, R. Casamitjana, J. Soler, Interactions between serum leptin, the insulin-like growth factor-1 system, and age, sex, anthropometric and body composition variables in a healthy population randomly selected. Clin. Endocrinol. 58, 213–219 (2003)CrossRefGoogle Scholar
  2. 2.
    M.S. Sandhu, A.H. Heald, J.M. Gibson, J.K. Cruickshank, D.B. Dunger, N.J. Wareham, Circulating concentrations of insulin-like growth factor-1 and development of glucose intolerance: a prospective observational study. Lancet 359, 1740–1745 (2002)PubMedCrossRefGoogle Scholar
  3. 3.
    H.J. Schneider, H. Wallaschofski, H. Völzke, M.R. Markus, M. Doerr, S.B. Felix, M. Nauck, N. Friedrich, Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality prediction. PLoS ONE 7(3), e33084 (2012)PubMedCrossRefGoogle Scholar
  4. 4.
    H. Völzke, M. Nauck, R. Rettig, M. Dörr, C. Higham, G. Brabant, H. Wallaschofski, Association between hepatic steatosis and serum IGF1 and IGFBP3 levels in a population-based sample. Eur. J. Endocrinol. 161, 705–713 (2007)CrossRefGoogle Scholar
  5. 5.
    A.H. Paredes, D.M. Torres, S.A. Harrison, Nonalcoholic fatty liver disease. Clin. Liver Dis. 16, 397–419 (2012)PubMedCrossRefGoogle Scholar
  6. 6.
    S. Rajaram, D.J. Baylink, S. Mohan, Insulin-like growth factor binding proteins in serum and other biological fluids: regulations and functions. Endocr. Rev. 18, 381–801 (1997)CrossRefGoogle Scholar
  7. 7.
    S.Y. Nam, E.J. Lee, K.R. Kim, B.S. Cha, Y.D. Song, S.K. Lim, H.C. Lee, K.B. Huh, Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int. J. Obes. Rel. Metab. Disord. 21, 355–359 (1997)CrossRefGoogle Scholar
  8. 8.
    A. Juul, K. Main, W.F. Blum, J. Lindholm, M.B. Ranke, N.E. Skakkebaek, The ratio between serum levels of insulin-like growth factor (IGF)-1 and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin. Endocrinol. 41, 85–93 (1994)CrossRefGoogle Scholar
  9. 9.
    M.A. Kirschner, N. Ertel, G. Schneider, Obesity, hormones, and cancer. Cancer Res. 41, 3711–3717 (1981)PubMedGoogle Scholar
  10. 10.
    P. Mårin, R. Rosmond, B.A. Bengtsson, C. Gustafsson, G. Holm, P. Björntorp, Growth hormone secretion after testosterone administration to men with visceral obesity. Obes. Res. 2, 263–270 (1994)PubMedCrossRefGoogle Scholar
  11. 11.
    M. Wabitsch, GH/IGF axis and longitudinal growth in children with obesity. J. Pediatr. Gastroenterol. Nutr. 51S, 145–146 (2010)CrossRefGoogle Scholar
  12. 12.
    J. Pineda, C. Dieguez, F.F. Casanueva, P. Martul, Decreased growth hormone response to dexamethasone stimulation test in obese children. Acta Paediatr. 83, 103–105 (1994)PubMedCrossRefGoogle Scholar
  13. 13.
    R.S. Yalow, S.M. Glick, J. Roth, S.A. Berson, Plasma and insulin and growth hormone levels in obesity and diabetes. Ann. N. Y. Acad. Sci. 131, 373–375 (1965)CrossRefGoogle Scholar
  14. 14.
    S. Yakar, J.L. Liu, B. Stannard, A. Butler, D. Accili, B. Sauer, D. LeRoith, Normal growth and development in the absence of hepatic insulin-like growth factor 1. Proc. Nat. Acad. Sci. 96, 7324–7329 (1999)PubMedCrossRefGoogle Scholar
  15. 15.
    M. Wabitsch, E. Heinze, K.M. Debatin, W.F. Blum, IGF-1 and IGFBP-3-expression in cultured human preadipocytes and adipocytes. Horm. Metab. Res. 32, 555–559 (2000)PubMedCrossRefGoogle Scholar
  16. 16.
    A. Guistina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008)CrossRefGoogle Scholar
  17. 17.
    K.E. Wong, J. Kong, W. Zhang, F.L. Szeto, H. Ye, D.K. Deb, M.J. Brady, Y.C. Li, Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice. J. Biol. Chem. 30, 3804–3810 (2011)Google Scholar
  18. 18.
    J.A. Johnson, J.P. Grande, P.C. Roche, R. Kumar, Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues. Histochem. Cell Biol. 105, 7–15 (1996)PubMedCrossRefGoogle Scholar
  19. 19.
    E. Kamycheva, R. Jorde, Y. Figenschau, E. Haug, Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity. J. Endocrinol. Invest. 30, 126–132 (2007)PubMedGoogle Scholar
  20. 20.
    P. Lips, Vitamin D physiology. Prog. Biophys. Mol. Biol. 92, 4–8 (2006)PubMedCrossRefGoogle Scholar
  21. 21.
    P.R. von Hurst, W. Stonehouse, J. Coad, Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient- a randomised, placebo-controlled trial. Br. J. Nutr. 103, 549–555 (2010)CrossRefGoogle Scholar
  22. 22.
    N.C. Bozkurt, E. Cakal, M. Sahin, E.C. Ozkaya, H. Firat, T. Delibasi, The relation of serum 25-hydroxyvitamin D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities. Endocrine 41, 518–525 (2012)PubMedCrossRefGoogle Scholar
  23. 23.
    M. Sneve, Y. Figenschau, R. Jorde, Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur. J. Endocrinol. 159, 675–684 (2008)PubMedCrossRefGoogle Scholar
  24. 24.
    B.L. Fisher, P. Schauer, Medical and surgical options in the treatment of severe obesity. Am. J. Surg. 184, S9–S16 (2002)CrossRefGoogle Scholar
  25. 25.
    H. Fukuoka, Y. Takahashi, K. Iida, T. Kudo, H. Nishizawa, M. Imanaka, R. Takeno, G. Iguchi, K. Takahashi, Y. Okimura, H. Kaji, K. Chinara, Low serum IGF-1/GH ratio is associated with abnormal glucose tolerance in acromegaly. Horm. Res. 69, 165–171 (2008)PubMedCrossRefGoogle Scholar
  26. 26.
    Y. Kinishita, H. Fujii, A. Takeshita, M. Taguchi, M. Miyakawa, K. Oyama, S. Yamada, Y. Takeuchi, Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic β-cell function is preserved. Eur. J. Endocrinol. 164, 467–473 (2011)CrossRefGoogle Scholar
  27. 27.
    A. Denley, J.M. Carrol, G.V. Cosgrove, J. Wallace, B. Forbes, C.T. Roberts Jr, Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol. Cell. Biol. 27, 3569–3577 (2007)PubMedCrossRefGoogle Scholar
  28. 28.
    K. Cleveland-Donovan, L. Maile, W.G. Tsiara, T. Tchkonia, J. Kirkland, C.M. Boney, IGF-1 activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects. Endocrinology 151, 3752–3763 (2010)PubMedCrossRefGoogle Scholar
  29. 29.
    D.E. Berryman, E.O. List, K.T. Coschigano, K. Behar, J.K. Kim, J.J. Kopchik, Comparing adiposity profiles in three mouse models with altered GH signalling. Growth. Horm. IGF Res. 14, 309–318 (2004)PubMedCrossRefGoogle Scholar
  30. 30.
    A. Guistina, J.D. Veldhuis, Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19, 717–797 (1998)CrossRefGoogle Scholar
  31. 31.
    H.W. Davidson, C.J. Rhodes, J.C. Hutton, Intraorganellar calcium and PH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature 333, 93–96 (1988)PubMedCrossRefGoogle Scholar
  32. 32.
    E. Hyppönen, B.J. Boucher, D.J. Berry, C. Power, 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age. Diabetes 57, 298–305 (2008)PubMedCrossRefGoogle Scholar
  33. 33.
    M. Matilainen, M. Malinen, K. Saavalainen, C. Carlberg, Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25hydroxyvitamin D3. Nucl. Acid Res. 33, 5521–5532 (2005)CrossRefGoogle Scholar
  34. 34.
    J.M. Gómez, The role of insulin-like growth factor 1 components in the regulation of vitamin D. Curr. Pharm. Biotechnol. 7, 125–132 (2006)PubMedCrossRefGoogle Scholar
  35. 35.
    H.O. El-Mesallamy, N.M. Hamdy, A.M. Sallam, Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients. Acta Diabetolog. Epub ahead of print (2012)Google Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of MedicineUniversity Hospital of North NorwayTromsøNorway
  2. 2.Endocrine Research Group, Institute of Clinical MedicineUniversity of TromsøTromsøNorway
  3. 3.Department of Laboratory MedicineUniversity Hospital of North NorwayTromsøNorway

Personalised recommendations